摘要 |
The present inventors have developed a key intermediate for the production of C2 substituted PBDs, which has a leaving group at the C2 position, a carbamate protecting group at the N10 position and a protected hydroxy group at the C11 position. In a first aspect, the present invention comprises a compound with a the formula (I), wherein: R<SUP>10 </SUP>is a carbamate-based nitrogen protecting group; R<SUP>11 </SUP>is an oxygen protecting group; and R<SUP>2 </SUP>is a labile leaving group. In a further aspect, the present invention comprises a method of synthesising a compound of formula (III), or a solvate thereof, from a compound of formula (I) as defined in the first aspect, R<SUP>16 </SUP>is either O-R11, wherein R<SUP>11 </SUP>is as defined in the first aspect, or OH, or R<SUP>10 </SUP>and R<SUP>16 </SUP>together form a double bond between N10 and C11; and R<SUP>15 </SUP>is R. The other substituents are defined in the claims. Further aspects of the present invention relate to compounds of formula (III) (including solvates thereof when R<SUP>10 </SUP>and R<SUP>16 </SUP>form a double bond between N10 and C11, and pharmaceutical salts thereof), pharmaceutical compositions comprising these, and their use in the manufacture of a medicament for the treatment of a proliferative disease.
|